Stephanie Bertenshaw
Professor at Naugatuck Valley Community College- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
-
Professor
-
-
Cheshire Public Schools
-
United States
-
Education Administration Programs
-
100 - 200 Employee
-
Teacher of Science
-
Aug 2000 - Aug 2022
Taught Honors and AP Chemistry. Biology, and Biotechnology courses. Author of chemistry curriculum. Toyota Tapestry Grant awardee. Taught Honors and AP Chemistry. Biology, and Biotechnology courses. Author of chemistry curriculum. Toyota Tapestry Grant awardee.
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Senior Research Scientist
-
Aug 1997 - Apr 2000
Designed, synthesized, and characterized novel melatonin receptor antagonists and ligands. Co-authored three published articles on melatonin antagonists and ligands. Designed, synthesized, and characterized novel melatonin receptor antagonists and ligands. Co-authored three published articles on melatonin antagonists and ligands.
-
-
-
-
Senior Research Scientist
-
Mar 1990 - Aug 1997
Designed, synthesized, and characterized novel endothelin converting enzyme, ECE, inhibitors. Wrote and co-authored three published articles on ECE inhibitors. Designed, synthesized, and characterized novel and selective cyclooxygenase-2, COX-2, inhibitors. Authored and co-authored three research publications and numerous patents on selective COX-2 inhibitors. Invented Celebrex. Designed, synthesized, and characterized novel endothelin converting enzyme, ECE, inhibitors. Wrote and co-authored three published articles on ECE inhibitors. Designed, synthesized, and characterized novel and selective cyclooxygenase-2, COX-2, inhibitors. Authored and co-authored three research publications and numerous patents on selective COX-2 inhibitors. Invented Celebrex.
-
-
Education
-
University of Illinois Chicago
Doctor of Philosophy - PhD, Organic Chemistry